Skip to main content
. 2022 Mar 9;3(4):100307. doi: 10.1016/j.jtocrr.2022.100307

Table 5.

irAEs by Sex for Patients With Lung Cancer From UH (2005–2020) Database

Feature UH
Male
1074 (51.1%)
Female
1028 (48.9%)
p Value
irAEs, n (%)a
Yes 472 (43.9) 448 (43.6) 0.89
Subtypes of irAEs, n (%)a
Rash or eczema 17 (1.6) 16 (1.6) 1
Diarrhea 28 (2.6) 45 (4.4) 0.03
Adrenal insufficiency 1 (0.1) 2 (0.2) 0.96
Hyperlipidemia 306 (28.5) 244 (23.7) 0.01
Nephritis 0 0
Leukopenia 15 (1.4) 15 (1.5) 1
Hypothyroidism 53 (4.9) 101 (9.8) <0.001
Hyperthyroidism 0 13 (1.3%) <0.001
Hypophysitis 25 (2.3) 27 (2.6) 0.76
Parathyroidism 3 (0.3) 7 (0.7) 0.30
Acute kidney injury 68 (6.3) 39 (3.8) 0.01
Neuritis 21 (2) 23 (2.2) 0.76
Hepatitis 11 (1) 5 (0.5) 0.24
Colitis 11 (1) 9 (0.9) 0.89
Pancreatitis 5 (0.5) 8 (0.8) 0.52
Mucositis 7 (0.7) 4 (0.4) 0.59
Arrhythmia 184 (17.1) 112 (10.9) <0.001
Myocardial infarction 25 (2.3) 12 (1.2) 0.06
Myocarditis 55 (5.1) 35 (3.4) 0.06
Pericarditis 20 (1.9) 13 (1.3) 0.35
Cardiomyopathy 33 (3.1) 12 (1.2) 0.004
Pneumonitis 116 (10.8) 100 (9.7) 0.46
Meningitis 0 0
Encephalopathy 4 (0.4) 2 (0.2) 0.72
Vitiligo 1 (0.1) 1 (0.1) 1
Thrombocytopenia 22 (2) 18 (1.8) 0.73
DM1 4 (0.4) 7 (0.7) 0.49

DM1, diabetes mellitus type 1; irAE, immune-related adverse event; UH, University Hospital.

a

Compared with Pearson’s chi-square test.